Recent advances have added substantially to our understanding of the biolog
y of estrogens. Estrogens are no longer considered to differ only in potenc
y. Two estrogens can have similar effects in one tissue and very different
effects in another. Additionally, an estrogen can have different effects in
different tissues. It is now recognized that there are at least two estrog
en receptors, ER-alpha and ER-beta, and that it is quite likely that estrog
ens also work through non-genomic mechanisms. The development of new method
s of chromatographic separation has aided substantially in our ability to c
haracterize the composition of Premarin, including the identification of es
tradiene, the fourth-most abundant estrogen in Premarin. Recent studies hav
e contributed to our understanding of the unique profile of Delta(8,9) dehy
droestrone sulfate, another of the Premarin estrogens. It was found that De
lta(8,9) dehydroestrone sulfate is an active estrogen with a distinct pharm
acological profile that results in significant clinical activity in vasomot
or, neuroendocrine and bone preservation parameters. However, it displayed
little or no efficacy, at the dose studied, on other peripheral parameters
normally affected by classical estrogens. Increasing knowledge of the uniqu
e profiles of the Premarin components, as well as their complex interaction
, will help to increase our understanding of the clinical profile of Premar
in. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.